Lymphoma
Latest updates in Hodgkin lymphoma from ISHL HL 2021
The International Symposium on Hodgkin Lymphoma (ISHL) 2021 Hodgkin Lymphoma (HL) update gathered an international panel to discuss the most…
Date: 20th April 2021
The Post-EBMT VJSessions from VJHemOnc
The 47th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) was held virtually this year and…
Date: 7th April 2021
Post-EBMT highlights in acute myeloid leukemia
Acute myeloid leukemia (AML) is the most common type of adult leukemia, with over 19,500 new cases estimated to be…
Date: 6th April 2021
The Lymphoma Sessions: highlights from ASH 2020
Lymphoma is a collection of cancers which develop in the lymphatic system and affect the lymphocytes. The risk factors for…
Date: 17th March 2021
Developments in CLL: MRD, LOXO-305 and venetoclax at ASH 2020
Chronic Lymphocytic Leukemia (CLL) is a B-cell malignancy, predominantly affecting the elderly, which is characterized by an accumulation of immunologically…
Date: 28th January 2021
Advances in CAR T-cell therapies for lymphoma from ASH 2020
Lymphoma is a group of malignant neoplasms of lymphocytes that progress in the lymphatic system. Generally, lymphomas are categorized into…
Date: 18th January 2021
The Lymphoma Sessions: highlights from iwNHL 2020
This year’s virtual International Workshop on Non-Hodgkin Lymphoma (iwNHL) highlighted key progress in our understanding of various non-Hodgkin lymphoma (NHL)…
Date: 18th November 2020
Advances in CAR-T and cellular therapy from EBMT 2020: MSCs, clinical trial updates and gene-edited effector cells
Cell therapy involves the transplantation of viable cells into a patient in order to trigger a medicinal effect. CAR-T is…
Date: 1st October 2020
SOHO 2020: Next questions in hematological malignancies
The Society of Hematologic Oncology (SOHO) 2020 Virtual Annual Meeting brought together global leading experts in hematological oncology who updated…
Date: 25th September 2020
Advances in the lymphoma space: targeted therapies, PET-guided omission of RT and CAR T-cells
Lymphoma encompasses a wide selection of cancers that progress in the lymphatic system. Broadly, two types of lymphoma exist, non-Hodgkin…
Date: 10th September 2020
The HemOnc & COVID-19 Sessions: treating hematological malignancies, reducing nosocomial COVID-19 infections, clinical trial participation and resource allocation
The ongoing COVID-19 pandemic caused by SARS-CoV-2 is an international public health issue and patients with cancer consistently demonstrate poorer…
Date: 28th July 2020
Harnessing the tumor microenvironment in lymphoma therapy
A deeper understanding of the characteristics, features and interactions at play in the tumor microenvironment has given great insight into…
Date: 2nd April 2020